COMMUNIQUÉS West-GlobeNewswire

Fractured Truth Campaign Wins Bronze Pearl Award for Content Marketing Excellence in the Healthcare/Pharmaceutical Industry

11/12/2017 - 19:30

WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) today announced that Fractured Truth—an unbranded patient campaign aimed to educate younger postmenopausal women about risks [...]

FDA Approves Sanofi's Admelog® (insulin lispro injection)

11/12/2017 - 19:11

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA Approves Sanofi's Admelog ® (insulin lispro injection) First FDA-approved follow-on mealtime insulin Admelog (insulin lispro injection) 100 Units/mL will be [...]

La FDA approuve l'insuline lispro injectable Admelog® de Sanofi

11/12/2017 - 19:11

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) La FDA approuve l'insuline lispro injectable Admelog ® de Sanofi Première insuline prandiale « follow-on » [1] approuvée par la FDA Admelog (insuline [...]

U.S. Army Dental Corps Veteran Honored by the American College of Prosthodontists

11/12/2017 - 18:49

Chicago, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Ronald D. Woody, DDS, FACP , was honored with the Major General Bill B. Lefler Federal Services Award at the Annual Awards & President’s Dinner during the American College [...]

RedHawk Completes EcoGen Share Transfer Agreement

11/12/2017 - 18:26

LAFAYETTE, La., Dec. 11, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today that along with its wholly-owned subsidiary, RedHawk Pharma UK Limited (“RedHawk Pharma [...]

Almirall and Athenex announce strategic partnership for the treatment of actinic keratosis

11/12/2017 - 17:31

Almirall and Athenex have entered into a strategic partnership to develop and commercialize KX2-391 in the United States and Europe KX2-391 is a first-in-class topical treatment currently in Phase III development that [...]

Ossur Hf : Transactions in relation to share buyback program

11/12/2017 - 17:01

Announcement from Össur hf. No. 86/2017 Reykjavík, 11 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Novartis drug crizanlizumab shown to prolong time to patients' first sickle cell pain crisis in subgroup analysis of SUSTAIN study

11/12/2017 - 16:51

Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle cell pain crisis, according to new subgroup analysis of Phase II SUSTAIN data Results were [...]

Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at 59th Annual ASH Meeting

11/12/2017 - 16:45

Encouraging initial anti-leukemic activity with durable responses and acceptable tolerability observed in dose expansion cohort Data supports combination with MGA012 (anti-PD-1) to potentially enhance anti-leukemic [...]

Thetis Builds Scientific Advisory Board to Guide Development of Immuno-Resolving Therapies for IBD

11/12/2017 - 16:35

BRANFORD, Conn., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals LLC (“Thetis”), a biopharmaceutical company developing oral, “immuno-resolving” therapies to treat inflammatory bowel disease (IBD), announced [...]

Reporting of transactions with ALK-Abelló A/S' B-shares and associated securities by person closely associated with person discharging managerial responsibly

11/12/2017 - 16:29

Copenhagen, 2017-12-11 16:29 CET (GLOBE NEWSWIRE) -- With reference to company announcement no. 35/2017 and no. 36/2017 regarding offering, pricing and completing of the offering of new shares in ALK-Abelló A/S, company [...]

Novo Nordisk A/S - Share repurchase programme

11/12/2017 - 16:03

Bagsværd, Denmark, 11 December 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Kura Oncology Identifies Potential Biomarkers of Activity for Lead Candidate Tipifarnib in Bone Marrow Cancers

11/12/2017 - 16:00

CXCR4/CXCR2 expression ratio and bone marrow homing of myeloid cells identified as potential markers for tipifarnib in MDS, AML and CMML CXCL12/CXCR4 pathway a potential therapeutic target of farnesyl transferase [...]

Bellicum Pharmaceuticals Announces Presentations of its Controllable Switch Technology Platform at the American Society of Hematology 2017 Annual Meeting

11/12/2017 - 16:00

ATLANTA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

BeiGene Presents Initial Phase 1b Data for BTK Inhibitor Zanubrutinib (BGB-3111) Combined with PD-1 Antibody Tislelizumab (BGB-A317) at the 59th American Society of Hematology Annual Meeting

11/12/2017 - 16:00

CAMBRIDGE, Mass. and BEIJING, China, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Atara Biotherapeutics Announces Updated Positive Interim Results from Multicenter Expanded Access Study of tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disorder (PTLD)

11/12/2017 - 16:00

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Clinical Data for eFFECTOR Therapeutics’ Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated Safety Profile

11/12/2017 - 16:00

Preclinical Data Shows Potential of eFT226 in B-cell Malignancies Data to be presented at the ASH 59 th Annual Meeting and Exposition SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in [...]

BioStem Technologies Inc. Announces a Pre-Clinical Study of BSEM17-115 at University of Miami

11/12/2017 - 15:43

Pompano Beach, FL, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”), in collaboration with the University of Miami’s Department of Dermatology and Cutaneous Surgery [...]

FRDJ salue la décision de l’ARC de revoir les refus des demandes pour le diabète

11/12/2017 - 15:33

TORONTO, 11 déc. 2017 (GLOBE NEWSWIRE) -- Les plus de 300 000 Canadiens et leur famille qui vivent avec le diabète de type 1 (DT1) au pays se réjouissent de l’annonce faite aujourd’hui du gouvernement du Canada et de l’ [...]